Insider · CIK 0001768239
Thomas Dolca
Reports to the SEC for 4 companies · MENLO PARK, CA
Transactions
30
Companies
4
Filings
11
CIK
0001768239
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-05-15 | Allakos Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-05-15 | Allakos Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2024-05-24 | Allakos Inc.Stock Option (Right to buy)A Award | — |
| 2023-08-11 | CHINOOK THERAPEUTICS, INC.D Disposition to Issuer | — |
| 2023-08-11 | CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer | −$593K |
| 2023-08-11 | CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer | −$138K |
| 2023-08-11 | CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer | −$347K |
| 2023-08-01 | Allakos Inc.Stock Option (Right to buy)A Award | — |
| 2023-05-26 | CHINOOK THERAPEUTICS, INC.M Exercise/Conversion | — |
| 2023-05-26 | CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsM Exercise/Conversion | — |
| 2022-09-02 | CHINOOK THERAPEUTICS, INC.P Purchase | +$206K |
| 2022-09-02 | CHINOOK THERAPEUTICS, INC.P Purchase | +$6,360 |
| 2022-05-26 | CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)A Award | — |
| 2022-05-26 | CHINOOK THERAPEUTICS, INC.Restricted Stock UnitA Award | — |
| 2021-06-04 | CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)A Award | — |
| 2021-01-11 | EQEquillium, Inc. · Stock Option (right to buy)A Award | — |
| 2020-10-06 | CHINOOK THERAPEUTICS, INC.Stock Option (right to buy)A Award | — |
| 2020-09-28 | Principia Biopharma Inc.U Disposition from Tender | −$221K |
| 2020-09-28 | Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2020-09-28 | Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2020-09-28 | Principia Biopharma Inc.Employee Stock Option (right to buy)D Disposition to Issuer | — |
| 2020-08-18 | Principia Biopharma Inc.M Exercise/Conversion | +$357K |
| 2020-08-18 | Principia Biopharma Inc.S Sale | −$1.5M |
| 2020-08-18 | Principia Biopharma Inc.Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-07-15 | Principia Biopharma Inc.M Exercise/Conversion | +$357K |
| 2020-07-15 | Principia Biopharma Inc.S Sale | −$1.2M |
| 2020-07-15 | Principia Biopharma Inc.Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-03-05 | Principia Biopharma Inc.Employee Stock Option (right to buy)A Award | — |
| 2019-12-19 | Principia Biopharma Inc.S Sale | −$29.7K |
| 2019-03-01 | Principia Biopharma Inc.Employee Stock Option (right to buy)A Award | — |
Recent filings
- 4Thomas Dolca0001104659-25-049419SEC(opens sec.gov)
- 4Thomas Dolca0000950170-24-065906SEC(opens sec.gov)
- 4Thomas Dolca0001209191-23-045430SEC(opens sec.gov)
- 4Thomas Dolca0001209191-23-044535SEC(opens sec.gov)
- 4Thomas Dolca0001209191-23-033186SEC(opens sec.gov)
- 4Thomas Dolca0001209191-22-048759SEC(opens sec.gov)
- 4Thomas Dolca0001209191-22-032960SEC(opens sec.gov)
- 4Thomas Dolca0001209191-21-038800SEC(opens sec.gov)
- 4Thomas Dolca0001209191-21-003422SEC(opens sec.gov)
- 4Thomas Dolca0001209191-20-054250SEC(opens sec.gov)
- 4Thomas Dolca0001209191-20-052226SEC(opens sec.gov)
Companies
Address
149 COMMONWEALTH DR, SUITE 1090
MENLO PARK, CA, 94025